CRISPR Journal

Papers
(The TQCC of CRISPR Journal is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Increasing Genome Editing Efficiency of Cas9 Nucleases by the Simultaneous Use of Transcriptional Activators and Histone Acetyltransferase Activator47
CRISPR Comparison Toolkit: Rapid Identification, Visualization, and Analysis of CRISPR Array Diversity37
Hairpin Internal Nuclear Localization Signals in CRISPR-Cas9 Enhance Editing in Primary Human Lymphocytes36
Adaptation by Type V-A and V-B CRISPR-Cas Systems Demonstrates Conserved Protospacer Selection Mechanisms Between Diverse CRISPR-Cas Types35
Will Advances in Genetic Medicine Lessen the Need for Germline Modifications?33
Exploring the Cytoplasmic Retention of CRISPR-Cas9 in Eukaryotic Cells: The Role of Nuclear Localization Signals and Ribosomal Interactions29
Subtypes of Type I-E CRISPR-Cas Systems Distribution in Human Escherichia coli Isolates from China29
Gene Editing Corrects In Vitro a G > A GLB1 Transition from a GM1 Gangliosidosis Patient28
Novel CRISPR-Associated Gene-Editing Systems Discovered in Metagenomic Samples Enable Efficient and Specific Genome Engineering23
Opposing Human Genetic Engineering23
The Lexicon of CRISPR: When Is It Too Much?22
Acknowledgment of Reviewers 202220
Curing “GFP-itis” in Bacteria with Base Editors: Development of a Genome Editing Science Program Implemented with High School Biology Students20
Advances in Cas12a-Based Amplification-Free Nucleic Acid Detection18
Generation of a Commercial-Scale Founder Population of Porcine Reproductive and Respiratory Syndrome Virus Resistant Pigs Using CRISPR-Cas18
Gene Editing and Rett Syndrome: Does It Make the Cut?17
Early Detection of Wildlife Disease Pathogens Using CRISPR-Cas System Methods16
Efficient Installation of Heterozygous Mutations in Human Pluripotent Stem Cells Using Prime Editing16
CRISPR Crops and Sustainable Agriculture15
Generation of Human Isogenic Induced Pluripotent Stem Cell Lines with CRISPR Prime Editing15
Comprehensive Analysis of CRISPR-Cas9 Editing Outcomes in Yeast Xanthophyllomyces dendrorhous15
Efficient Homology-Directed Repair with Circular Single-Stranded DNA Donors14
The Roles and Responsibilities of Scientific Journals in Research Governance: Editorial Policymaking at Nature and Springer Nature (1995–2023)14
CRISPR-Cas9 Single Nucleotide Editing of Tuberous Sclerosis Complex 2 Gene in Mesenchymal Stem Cells13
Viability-Based Assessment Reveals True Efficiency of CRISPR-Cas9 Transfection Methods in Rabbit Spermatozoa13
Engineered Antiviral Sensor Targets Infected Mosquitoes13
A Story of Perseverance: An Interview with Matthew Porteus12
Institutional Bioethics: From Critical Interdisciplinarity to Cosmopolitanism12
Automated Good Manufacturing Practice-Compatible CRISPR-Cas9 Editing of Hematopoietic Stem and Progenitor Cells for Clinical Treatment of β-Hemoglobinopathies12
Regulatory Support for CRISPR in Ag: A Timely EU-Turn12
Widespread Impact of Natural Genetic Variations in CRISPR-Cas9 Outcomes12
Gene Editing in the Chagas Disease Vector Rhodnius prolixus by Cas9-Mediated ReMOT Control12
Specific High-Sensitivity Enzymatic Reporter UnLOCKing-Mediated Detection of Oncogenic BCR::ABL1 and EGFR 12
A PCR-Induced Mutagenesis-Restriction Fragment Length Polymorphism Method for the Detection of CRISPR-Induced Indels11
Efficient CRISPR-Cas9-Mediated Genome Editing of the Cane Toad ( Rhinella marina )11
dCas9 Tells Tales: Probing Gene Function and Transcription Regulation in Cancer11
Fanzors: Mysterious TnpB-Like Bacterial Transposon-Related RNA-Guided DNA Nucleases of Eukaryotes11
Enhancements of the CRISPR-Cas System in the Silkworm Bombyx mori11
CRISPR Momentum in the Clinic and the Field11
Engineering CjCas9 for Efficient Base Editing and Prime Editing11
A Multiplexed Cas13-Based Assay with Point-of-Care Attributes for Simultaneous COVID-19 Diagnosis and Variant Surveillance10
A Fluorescent Reporter Mouse for In Vivo Assessment of Genome Editing with Diverse Cas Nucleases and Prime Editors10
Conditional Expression of Cas9 and dCas9 in Lucilia cuprina Reveals dCas9-Associated Lethality10
Affordable Pricing of CRISPR Treatments is a Pressing Ethical Imperative10
A Protein-Cutting CRISPR Complex Caught in Action10
CRISPR-Cas9-Mediated Correction of TSC2 Pathogenic Variants in iPSCs from Patients with Tuberous Sclerosis Complex Type 29
Rapid and Technically Simple Detection of SARS-CoV-2 Variants Using CRISPR Cas12 and Cas139
Warrior Spirit: An Interview with Victoria Gray, Sickle Cell Pioneer9
It's a Knockout for Cat Allergies?9
The CRISPR Revolution in the Drug Discovery Workflow: An Industry Perspective9
Cas12a-Capture: A Novel, Low-Cost, and Scalable Method for Targeted Sequencing9
Navigating Viral Space with CRISPR Technologies8
Acknowledgment of Reviewers 20238
Rapid Variant Pathogenicity Analysis by CRISPR Activation of CRB1 Gene Expression in Patient-Derived Fibroblasts8
Introducing Faith-Based Claims to Ethical Discourse on Scientific Matters8
CRISPR Medicine Needs Infrastructure, Not Just Innovation7
Genome Editing Headwinds: Can CRISPR Stay on Target?7
The New Old Colonialism7
Five Years of Progress in CRISPR Clinical Trials (2019–2024)7
Strategies for Interdisciplinary Human Gene Editing Research: Insights from a Swiss Project7
Reduction of Pre-Existing Adaptive Immune Responses Against SaCas9 in Humans Using Epitope Mapping and Identification7
Genome Editing Therapy for the Blood: Ex Vivo Success and In Vivo Prospects7
Trichostatin A for Efficient CRISPR-Cas9 Gene Editing of Human Pluripotent Stem Cells7
0.12843799591064